View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Rain Check, Please! Truly Hard Seltzer is Paying Fans with a “Rain Che...

Rain Check, Please! Truly Hard Seltzer is Paying Fans with a “Rain Check” to Use on Their Next Pack If Fourth of July Plans Get Rained Out We can’t guarantee the weather, but we can guarantee delicious fruity refreshment with the new, limited-edition Truly Pool Party Variety Pack BOSTON, MA, June 18, 2025 (GLOBE NEWSWIRE) -- Summer weather can be unpredictable – and nothing puts a damper on a holiday weekend like a rained-out pool party. With recent rainfall trends tracking higher than usual1 and forecasts pointing to a wetter-than-average summer in portions of the nation2, it’s safe to...

 PRESS RELEASE

Dogfish Head Dubbed Official Beer of JAWS 50th Anniversary Celebration...

Dogfish Head Dubbed Official Beer of JAWS 50th Anniversary Celebrations MILTON, Del., June 18, 2025 (GLOBE NEWSWIRE) -- “We’re gonna need a bigger boat” … er, beer! joins forces with the Martha’s Vineyard Chamber of Commerce to celebrate the 50th anniversary of the iconic shark film, JAWS. As the “Official Beer of JAWS 50th Anniversary Celebrations,” Dogfish Head and its products will be prominently featured at the Martha Vineyard Chamber of Commerce’s happening this weekend – Friday, June 20, and Saturday, June 21 – on Martha’s Vineyard, where the original film was shot. Drinkers wil...

 PRESS RELEASE

Simply Good Foods to Report Third Quarter Fiscal Year 2025 Financial R...

Simply Good Foods to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, July 10, 2025 DENVER, June 18, 2025 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced it will report financial results for the thirteen week period ended May 31, 2025, on Thursday, July 10, 2025, before market open. The Company will host a conference call to discuss these results with additional comments and details provided at that time. Particip...

 PRESS RELEASE

Weatherford Announces Second-Quarter 2025 Conference Call

Weatherford Announces Second-Quarter 2025 Conference Call HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) will host a conference call on Wednesday, July 23, 2025 to discuss the Company’s results for the second quarter ended June 30, 2025. The conference call will begin at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). Prior to the conference call, the Company will issue a press release announcing the results and the associated presentation slides will be uploaded to the investor relations section of the Weatherfor...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 14, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

FibroGen Announces 1-for-25 Reverse Stock Split

FibroGen Announces 1-for-25 Reverse Stock Split SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on June 16, 2025. FibroGen’s common stock will begin trading on a split-adjusted basis on June 17, 2025, when the markets open, under the Company’s existing trading symbol “FGEN,” with the new CUSIP number 31572Q881. The Reverse Stock Split was previously approved by stockholders at the Compa...

 PRESS RELEASE

SAMUEL ADAMS AWARDS MOOR’S BREWING CO 2025 BREWING & BUSINESS EXPERIEN...

SAMUEL ADAMS AWARDS MOOR’S BREWING CO 2025 BREWING & BUSINESS EXPERIENCESHIP Brewing the American Dream Program Continues Legacy of Small Business Support with New Top Craft Brewer Selection Boston, MA, June 12, 2025 (GLOBE NEWSWIRE) -- , the philanthropic program supporting food and beverage entrepreneurs nationwide, proudly announces Moor’s Brewing Co. as the 2025 winner of its prestigious Brewing & Business Experienceship. Now in its 14th year, the program welcomes this standout craft brewer into an esteemed community of innovators and changemakers in the beer industry. Each year, ...

Moody's Ratings assigns Caa2 rating to KLXE's secured notes due 2030, ...

Moody's Ratings (Moody's) assigned a Caa2 rating to KLX Energy Services Holdings, Inc.'s (KLXE) senior secured notes due 2030 and changed the ratings outlook to stable from negative. The Caa1 Corporate Family Rating (CFR) and Caa1-PD Probability of Default Rating (PDR) were affirmed. The Speculative...

 PRESS RELEASE

AMERANT BANK ANNOUNCES HIRE OF ELLIOT SHAFER AS NEW HEAD OF BUSINESS D...

AMERANT BANK ANNOUNCES HIRE OF ELLIOT SHAFER AS NEW HEAD OF BUSINESS DEVELOPMENT MIAMI, FL, June 09, 2025 (GLOBE NEWSWIRE) -- Amerant Bank, Florida’s bank of choice with a growing presence across South Florida, has named Elliot Shafer as SVP, Head of Business Development. In this key role, Shafer will support Amerant’s growth by identifying, evaluating, and pursuing business opportunities that align with Amerant’s strategic objectives across all lines of business. “We are excited to welcome Elliot to the team,” said Jerry Plush, Chairman and CEO. “His extensive experience in business d...

 PRESS RELEASE

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Direct...

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025. “Michael is a well-recognized biotech industry veteran, who brings a wealth of biotech leadership experience to our board,” said James Schoeneck, chairman of the board of directors of FibroGen. “His expertise spanning all stages of drug development will be invaluable as FibroGen progresses its pipeline. Michael’s deep understanding o...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 7, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 5, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

TWISTED TEA HARD ICED TEA UNLEASHES ITS BEST SUMMER LINEUP YET WITH A ...

TWISTED TEA HARD ICED TEA UNLEASHES ITS BEST SUMMER LINEUP YET WITH A DELICIOUSLY REFRESHING FLAVOR FOR EVERY FAN Rocket Pop returns, Extreme goes national, and Light gets loud, proving no one does summer quite like Twisted Tea BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- If you needed an excuse to crack open an ice-cold can of Twisted Tea Hard Iced Tea, let this be it! This summer, America’s favorite hard iced tea* is bringing more flavor to fans across the country with a lineup as bright and colorful as the Fourth of July. Whether you’re feeling nostalgic, looking to turn up the flavor o...

 PRESS RELEASE

Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial...

Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced an update on the Phase 2 IGNITE open-label clinical trial evaluating iluzanebart, a monoclonal antibody TREM2 agonist, for the potential treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Iluzanebart demonstrated a favorable saf...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
BLDR BUILDERS FIRSTSOURCE INC.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
PINS PINTEREST INC. CLASS A
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
APRE APREA THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
UFPI UFP INDUSTRIES INC.
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
NUVB NUVATION BIO INC (A)
RBLX ROBLOX
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
TCRX TSCAN THERAPEUTICS INC
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
NUVL NUVALENT INC
ARTV ARTIVA BIOTHERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
BCAX BICARA THERAPEUTICS INC.
David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Dylan Shindler
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Yun Zhong
Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: June 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch